Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Epigenetic modifications, including DNA methylation and histone modifications, regulate gene expression by altering chromatin states.
• These epigenetic events are critical in cancer initiation and progression, often repressing tumor suppressor genes or activating oncogenic pathways.
• The recruitment of DNA methyltransferases to specific genomic regions is dynamically regulated by histone marks, transcription factors, and co-regulators.

Purpose of the Study:

• To review the mechanisms by which epigenetic modifications, particularly DNA methylation, are involved in cancer.
• To present the current state-of-the-art in DNA methylation research within the context of cancer.
• To discuss the development of epigenetic cancer therapies targeting DNA methylation.

Main Methods:

• Review of existing literature on epigenetic modifications in cancer.
• Analysis of mechanisms involving DNA methylation and its regulators.
• Examination of current and developing therapeutic strategies targeting DNA methylation.

Main Results:

• Epigenetic modifications play a significant role in cancer development and progression.
• DNA methylation is a key epigenetic mechanism implicated in oncogenesis.
• Targeting DNA methylation represents a promising avenue for novel cancer therapies.

Conclusions:

• Epigenetic modifications are fundamental to cancer biology.
• Understanding the interplay of DNA methylation and other epigenetic marks is crucial for cancer treatment.
• Epigenetic therapies targeting DNA methylation hold significant potential for future cancer treatment strategies.